{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+care+without+prophylaxis", "query": { "intervention": "Standard of care without prophylaxis" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 75, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+care+without+prophylaxis&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-21T02:43:42.934Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01050153", "title": "The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Venous Thromboembolism" ], "interventions": [ { "name": "Dalteparin sodium", "type": "DRUG" }, { "name": "Dalteparin sodium/aspirin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Denver Health and Hospital Authority", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2010-03", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2019-01-08", "last_synced_at": "2026-09-21T02:43:42.934Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01050153" }, { "nct_id": "NCT00157157", "title": "Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hemophilia A" ], "interventions": [ { "name": "Recombinant Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Baxalta now part of Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "6 Years", "sex": "ALL", "summary": "Up to 6 Years" }, "enrollment_count": 66, "start_date": "2004-04-01", "completion_date": "2009-09-11", "has_results": true, "last_update_posted_date": "2021-05-24", "last_synced_at": "2026-09-21T02:43:42.934Z", "location_count": 17, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 14 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00157157" }, { "nct_id": "NCT06611553", "title": "Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cervical Carcinoma", "Human Papillomavirus Infection" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cervical Biopsy", "type": "PROCEDURE" }, { "name": "Colposcopy", "type": "PROCEDURE" }, { "name": "Electronic Health Record Review", "type": "OTHER" }, { "name": "Endocervical Curettage", "type": "PROCEDURE" }, { "name": "Excision", "type": "PROCEDURE" }, { "name": "HPV Self-Collection", "type": "PROCEDURE" }, { "name": "Human Papillomavirus Test", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "FEMALE", "summary": "25 Years and older · Female only" }, "enrollment_count": 500, "start_date": "2024-09-13", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-09-21T02:43:42.934Z", "location_count": 13, "location_summary": "Birmingham, Alabama • New Haven, Connecticut • Miami, Florida + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06611553" }, { "nct_id": "NCT07285460", "title": "A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hemophilia" ], "interventions": [ { "name": "Fitusiran", "type": "DRUG" }, { "name": "Clotting factor concentrates (CFC) or bypassing agents (BPA)", "type": "BIOLOGICAL" }, { "name": "Antithrombin concentrate (ATIIIC)", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "11 Years", "sex": "MALE", "summary": "1 Year to 11 Years · Male only" }, "enrollment_count": 85, "start_date": "2025-12-18", "completion_date": "2031-12-30", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-09-21T02:43:42.934Z", "location_count": 5, "location_summary": "Los Angeles, California • Orange, California • Las Vegas, Nevada + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Hackensack", "state": "New Jersey" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07285460" }, { "nct_id": "NCT01910350", "title": "Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Cervical Cancer" ], "interventions": [ { "name": "Kin KeeperSM Cancer Prevention Intervention", "type": "BEHAVIORAL" }, { "name": "Standard of care", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Michigan State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "21 Years to 70 Years · Female only" }, "enrollment_count": 516, "start_date": "2010-07", "completion_date": "2015-06", "has_results": false, "last_update_posted_date": "2015-09-25", "last_synced_at": "2026-09-21T02:43:42.934Z", "location_count": 1, "location_summary": "East Lansing, Michigan", "locations": [ { "city": "East Lansing", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01910350" }, { "nct_id": "NCT05557877", "title": "Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Carcinoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Low-Dose Aspirin", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 60, "start_date": "2023-03-09", "completion_date": "2027-01-30", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-09-21T02:43:42.934Z", "location_count": 5, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Indianapolis, Indiana + 2 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05557877" }, { "nct_id": "NCT03066466", "title": "Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Myeloid Leukemia", "Acute Lymphocytic Leukemia", "Myelodysplastic Syndrome" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loyola University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2019-12-10", "completion_date": "2021-02-28", "has_results": false, "last_update_posted_date": "2021-04-27", "last_synced_at": "2026-09-21T02:43:42.934Z", "location_count": 1, "location_summary": "Maywood, Illinois", "locations": [ { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03066466" }, { "nct_id": "NCT06965712", "title": "Use of Point-of-Care Ultrasound (POCUS) to Reduce Hospital Length of Stay in Patients With Heart Failure ( POCUSHF )", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Failure", "Decompensated Heart Failure", "Hospital Length of Stay" ], "interventions": [ { "name": "Point-of-Care Ultrasound (POCUS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Florida International University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 66, "start_date": "2025-11-24", "completion_date": "2026-07-10", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-09-21T02:43:42.934Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06965712" }, { "nct_id": "NCT07285486", "title": "Regenerative Peripheral Nerve Interfaces for the Treatment of Painful Neuromas in Major Limb Amputees", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Amputation Neuroma" ], "interventions": [ { "name": "Amputation with Regenerative Peripheral Nerve Interfaces (RPNI)", "type": "PROCEDURE" }, { "name": "Amputation Without RPNI", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 132, "start_date": "2017-06-08", "completion_date": "2023-06-26", "has_results": false, "last_update_posted_date": "2025-12-16", "last_synced_at": "2026-09-21T02:43:42.934Z", "location_count": 2, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07285486" }, { "nct_id": "NCT04999592", "title": "Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Out-Of-Hospital Cardiac Arrest", "Pneumonia" ], "interventions": [ { "name": "Standard of care without prophylaxis", "type": "DRUG" }, { "name": "Antibiotic prophylaxis", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David J. Gagnon", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 53, "start_date": "2021-08-20", "completion_date": "2024-11-01", "has_results": true, "last_update_posted_date": "2025-04-17", "last_synced_at": "2026-09-21T02:43:42.934Z", "location_count": 1, "location_summary": "Portland, Maine", "locations": [ { "city": "Portland", "state": "Maine" } ], "official_url": "https://clinicaltrials.gov/study/NCT04999592" } ] }